Clinical outcome and the value of diagnostic I-131 whole body scintigraphy and recombinant TSH in low-risk well differentiated thyroid cancer patients who have had I-131 radioablation and undetectable thyroglobulin levels

dc.contributor.authorArgon, M.
dc.contributor.authorYararbas, U.
dc.contributor.authorKumanlioglu, K.
dc.contributor.authorOzkilic, H.
dc.date.accessioned2019-10-27T21:41:02Z
dc.date.available2019-10-27T21:41:02Z
dc.date.issued2012
dc.departmentEge Üniversitesien_US
dc.description25th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) -- OCT 27-31, 2012 -- Milan, ITALYen_US
dc.description.sponsorshipEuropean Assoc Nucl Med (EANM)en_US
dc.identifier.endpageS560en_US
dc.identifier.issn1619-7070
dc.identifier.startpageS560en_US
dc.identifier.urihttps://hdl.handle.net/11454/46513
dc.identifier.volume39en_US
dc.identifier.wosWOS:000309726603249en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal of Nuclear Medicine and Molecular Imagingen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleClinical outcome and the value of diagnostic I-131 whole body scintigraphy and recombinant TSH in low-risk well differentiated thyroid cancer patients who have had I-131 radioablation and undetectable thyroglobulin levelsen_US
dc.typeConference Objecten_US

Dosyalar